FBRX FORTE BIOSCIENCES INC
FollowCOMMON STOCK (common)
Filings received so far for Q3 2026: 1 13F filer report a position in FBRX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- ORBIMED ADVISORS LLC(group ORBIMED ADVISORS LLC)
0 shares, 0% in a 13G/A as of 2026-09-30,0000947871-26-001031
Accepted , ingested - GLAZER CAPITAL, LLC(group GLAZER CAPITAL, LLC)
0 shares, 0% in a 13G/A as of 2026-09-30,0001076809-26-000165
Accepted , ingested - TYBOURNE CAPITAL MANAGEMENT (HK) LTD(group TYBOURNE CAPITAL MANAGEMENT (HK) LTD)
0 shares, 0% in a 13G/A as of 2026-09-30,0000929638-26-004231
Accepted , ingested - MPM BIOIMPACT LLC
0 shares, 0% in a 13G/A as of 2026-09-30,0001687078-26-000026
Accepted , ingested - Affinity Asset Advisors, LLC(group Affinity Asset Advisors, LLC)
0 shares, 0% in a 13G/A as of 2026-09-30,0001011438-26-000693
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| IFP Advisors, Inc | 3 | $231 | <0.01% | new | 13F-HRTimeline |
Events
ORBIMED ADVISORS LLC and 2 other reporting persons reported 0 FBRX shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0000947871-26-001031
Accepted , ingestedGLAZER CAPITAL, LLC and 1 other reporting person reported 0 FBRX shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001076809-26-000165
Accepted , ingestedAffinity Asset Advisors, LLC and 1 other reporting person reported 0 FBRX shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-13. 0001011438-26-000693
Accepted , ingestedMPM BIOIMPACT LLC reported 0 FBRX shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-13. 0001687078-26-000026
Accepted , ingestedTYBOURNE CAPITAL MANAGEMENT (HK) LTD and 3 other reporting persons reported 0 FBRX shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-04. 0000929638-26-004231
Accepted , ingested